Latest news on ‘Health & Drug’
-
Investors dump shares of Wellpoint, down 2.2% (WLP)
WellPoint (NYSE:WLP) is one of today’s worst performing stocks, down 2.2% to $50.19. The S&P is currently trading 1% lower to 1,116 and the Dow Jones Industrial Average is trading [...]
-
P&G 3Q profit dips despite sales jump
CINCINNATI (AP) — Consumer products giant Procter & Gamble Co. reported Thursday that its profit fell 1 percent in its third quarter, hurt by charges including from the U.S. health [...]
-
For $520 Million, AstraZeneca Settles Case Over Marketing of a Drug
By DUFF WILSON – AstraZeneca has completed a deal to pay $520 million to settle federal investigations into marketing practices for its blockbuster schizophrenia drug, Seroquel, the Attorney General, Eric [...]
-
Charles River, Chinese Pharma Firm Ink $1.6B Deal
HONG KONG – Charles River Laboratories plans to buy Shanghai-based pharmaceutical outsourcing provider WuXi PharmaTech in a $1.6 billion cash-and-stock deal, the companies announced Monday.
Once complete, the deal could mark [...] -
Judge Invalidates Human Gene Patent
NY Times – A federal judge on Monday struck down patents on two genes linked to breast and ovarian cancer. The decision, if upheld, could throw into doubt the patents [...]
-
Wall Street little changed as healthcare shares rise
NEW YORK (Reuters) – Stocks rose on Monday led by the healthcare sector after the House of Representatives passed a healthcare reform bill, providing clarity following months of uncertainty.
While analysts [...] -
Factbox: Teva Pharmaceutical’s history of acquisitions
(Reuters) – Teva Pharmaceutical Industries (TEVA.O) (TEVA.TA) said on Thursday it would acquire Germany’s Ratiopharm for 3.625 billion euros ($4.95 billion) including debt.
Below are major acquisitions by Teva, Israel’s largest [...] -
Germany’s Merkel: Euro Helped Euro Zone Through Crisis
HANNOVER, Germany (Dow Jones) – The strength of the euro helped European countries that share the common currency overcome the economic crisis, Germany’s Chancellor Angela Merkel said Monday.
“The euro brought [...] -
CVS Caremark 4Q Profit Rises 10% Amid Revenue Strength
NEW YORK (Dow Jones) – CVS Caremark Corp.’s (CVS) fourth-quarter earnings rose 10% amid stronger sales at its pharmacy businesses while the hybrid drug-store pharmacy benefit manager’s chief executive expressed [...]
-
Pfizer 4Q Net Doubles; Earnings View Below Street
By Peter Loftus
Pfizer Inc.’s (PFE) fourth-quarter earnings more than doubled from a year-earlier profit that was dampened by a legal settlement, while the acquisition of Wyeth helped push sales up [...]
